{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:28:49Z","timestamp":1793125729929,"version":"4.5.0"},"reference-count":75,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,10,15]]},"DOI":"10.2169\/internalmedicine.4516-20","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T22:06:10Z","timestamp":1593468370000},"page":"2471-2480","source":"Crossref","is-referenced-by-count":28,"title":["Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations"],"prefix":"10.2169","volume":"59","author":[{"given":"Pei-lin","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Hodes","sequence":"additional","affiliation":[{"name":"Marquette University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-yue","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 20: 125-129, 1999."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Garcia-Monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what&apos;s in a name? J Neuroimaging 21: e1-e14, 2011.","DOI":"10.1111\/j.1552-6569.2008.00279.x"},{"key":"3","unstructured":"3. Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 70: 459-463, 2001."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Mirsattari SM, Lee DH, Jones MW, Blume WT. Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology 60: 1838-1841, 2003.","DOI":"10.1212\/01.WNL.0000058754.99940.11"},{"key":"5","unstructured":"5. Jing C, Sun L, Wang Z, Chu C, Lin W. Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review. J Int Med Res 46: 1277-1281, 2018."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Neshige S, Kanaya Y, Takeshima S, Yoshimoto T, Tanaka A, Kuriyama M. [Reversible changes on MR images in a patient with metronidazole-induced encephalopathy]. Rinsho Shinkeigaku (Clin Neurol) 55: 174-177, 2015 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.55.174"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kaino K, Kumagai R, Furukawa S, et al. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine. J Diabetes Investig 8: 392-394, 2017.","DOI":"10.1111\/jdi.12597"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takayanagi M, Okabe S, Yamamoto K, et al. Kleine-Levin syndrome elicited by encephalopathy with reversible splenial lesion. Pediatr Int 59: 929-931, 2017.","DOI":"10.1111\/ped.13326"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Takatsu H, Ishimaru N, Ito M, Kinami S. Mild encephalitis\/encephalopathy with a reversible splenial lesion in an adult patient with influenza. Intern Med 56: 3093-3095, 2017.","DOI":"10.2169\/internalmedicine.8997-17"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Karampatsas K, Spyridou C, Morrison IR, Tong CY, Prendergast AJ. Rotavirus-associated mild encephalopathy with a reversible splenial lesion (MERS)-case report and review of the literature. BMC Infect Dis 15: 446, 2015.","DOI":"10.1186\/s12879-015-1192-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Avcu G, Kilinc MA, Eraslan C, Karapinar B, Vardar F. Mild encephalitis\/encephalopathy with reversible splenial lesion (MERS) associated with <i>Streptococcus pneumoniae<\/i> Bacteraemia. J Infect Public Health 10: 479-482, 2017.","DOI":"10.1016\/j.jiph.2016.08.019"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hayashi Y, Yasunishi M, Hayashi M, Asano T, Kimura A, Inuzuka T. Reversible splenial lesion of the corpus callosum associated with meningococcal meningitis. J Neurol Sci 373: 81-82, 2017.","DOI":"10.1016\/j.jns.2016.12.035"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maeda M, Tsukahara H, Terada H, et al. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol 33: 229-236, 2006.","DOI":"10.1016\/S0150-9861(06)77268-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takanashi J, Tada H, Maeda M, Suzuki M, Terada H, Barkovich AJ. Encephalopathy with a reversible splenial lesion is associated with hyponatremia. Brain Dev 31: 217-220, 2009.","DOI":"10.1016\/j.braindev.2008.04.002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jeong TO, Yoon JC, Lee JB, Jin YH, Hwang SB. Reversible splenial lesion syndrome (RESLES) following glufosinate ammonium poisoning. J Neuroimaging 25: 1050-1052, 2015.","DOI":"10.1111\/jon.12216"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Theeler BJ, Wilson DJ, Crawford CM, Grazko M. Optic neuropathy and a reversible splenial lesion after gastric bypass: shared pathophysiology? J Neurol Sci 291: 92-94, 2010.","DOI":"10.1016\/j.jns.2010.01.015"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kosugi T, Isoda H, Imai M, Sakahara H. Reversible focal splenial lesion of the corpus callosum on MR images in a patient with malnutrition. Magn Reson Med Sci 3: 211-214, 2004.","DOI":"10.2463\/mrms.3.211"},{"key":"18","unstructured":"18. Pan JJ, Zhao YY, Lu C, Hu YH, Yang Y. Mild encephalitis\/encephalopathy with a reversible splenial lesion: five cases and a literature review. Neurol Sci 36: 2043-2051, 2015."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Soon GS, Rodan LH, Laughlin S, Laxer RM, Benseler S, Silverman ED. Reversible splenial lesion syndrome in pediatric systemic lupus erythematosus. J Rheumatol 39: 1698-1699, 2012.","DOI":"10.3899\/jrheum.120390"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Itamura S, Kamada M, Nakagawa N. Kawasaki disease complicated with reversible splenial lesion and acute myocarditis. Pediatr Cardiol 32: 696-699, 2011.","DOI":"10.1007\/s00246-011-9937-4"},{"key":"21","unstructured":"21. Gilder TR, Hawley JS, Theeler BJ. Association of reversible splenial lesion syndrome (RESLES) with anti-VGKC autoantibody syndrome: a case report. Neurol Sci 37: 817-819, 2016."},{"key":"22","unstructured":"22. Liu J, Liu D, Yang B, et al. Reversible splenial lesion syndrome (RESLES) coinciding with cerebral venous thrombosis: a report of two cases. Ther Adv Neurol Disord 10: 375-379, 2017."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chen Z, Xu M, Shang D, Luo B. A case of reversible splenial lesions in late postpartum preeclampsia. Intern Med 51: 787-790, 2012.","DOI":"10.2169\/internalmedicine.51.6500"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zhu Y, Zheng J, Zhang L, et al. Reversible splenial lesion syndrome associated with encephalitis\/encephalopathy presenting with great clinical heterogeneity. BMC Neurol 16: 49, 2016.","DOI":"10.1186\/s12883-016-0572-9"},{"key":"25","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000144274.12174.CB","volume":"63","author":"H Tada","year":"2004","unstructured":"25. Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis\/encephalopathy with a reversible splenial lesion. Neurology 63: 1854-1858, 2004.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"26","unstructured":"26. Zhang S, Ma Y, Feng J. Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity. Medicine (Baltimore) 94: e512, 2015."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yuan J, Yang S, Wang S, Qin W, Yang L, Hu W. Mild encephalitis\/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review. BMC Neurol 17: 103, 2017.","DOI":"10.1186\/s12883-017-0875-5"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Notebaert A, Willems J, Coucke L, Van Coster R, Verhelst H. Expanding the spectrum of MERS type 2 lesions, a particular form of encephalitis. Pediatr Neurol 48: 135-138, 2013.","DOI":"10.1016\/j.pediatrneurol.2012.10.003"},{"key":"29","unstructured":"29. Dong K, Zhang Q, Ding J, et al. Mild encephalopathy with a reversible splenial lesion mimicking transient ischemic attack: a case report. Medicine (Baltimore) 95: e5258, 2016."},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia 46: 1633-1636, 2005.","DOI":"10.1111\/j.1528-1167.2005.00256.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 62: 433-437, 2005.","DOI":"10.1001\/archneur.62.3.433"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hara M, Mizuochi T, Kawano G, et al. A case of clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination. Brain Dev 33: 842-844, 2011.","DOI":"10.1016\/j.braindev.2010.12.013"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Merizalde M, Navalon P, Gonzalez MF, Dominguez A, Livianos L, Martinez JC. Manic espisode, confusional syndrome and reversible splenial lesion after abrupt withdrawal of oxcarbazepine. J Affect Disord 210: 122-124, 2017.","DOI":"10.1016\/j.jad.2016.12.018"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sawagashira R, Narita H, Hashimoto N, et al. Transient lesions of the splenium of the corpus callosum following rapid withdrawal of levetiracetam. Epileptic Disord 19: 379-382, 2017.","DOI":"10.1684\/epd.2017.0923"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Duberkar D, Jawale R. Transient lesion in the splenium of corpus callosum due to abrupt phenytoin withdrawal. Neurol India 65 (Suppl): S104, 2017.","DOI":"10.4103\/neuroindia.NI_875_16"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. \u00d6ztoprak \u00ce, Engin A, G\u00fcm\u00fcs C, Egilmez H, \u00d6ztoprak B. Transient splenial lesions of the corpus callosum in different stages of evolution. Clin Radiol 62: 907-913, 2007.","DOI":"10.1016\/j.crad.2007.04.012"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Tomizawa Y, Hoshino Y, Sasaki F, et al. Diagnostic utility of splenial lesions in a case of Legionnaires&apos; disease due to <i>Legionella pneumophila<\/i> serogroup 2. Intern Med 54: 3079-3082, 2015.","DOI":"10.2169\/internalmedicine.54.4872"},{"key":"38","unstructured":"38. Vollmann H, Hagemann G, Mentzel HJ, Witte OW, Redecker C. Isolated reversible splenial lesion in tick-borne encephalitis: a case report and literature review. Clin Neurol Neurosurg 113: 430-433, 2011."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Renard D, Taieb G, Briere C, Bengler C, Castelnovo G. Mild encephalitis\/encephalopathy with a reversible splenial, white matter, putaminal, and thalamic lesions following anti-Yo rhombencephalitis. Acta Neurol Belg 112: 405-407, 2012.","DOI":"10.1007\/s13760-012-0080-7"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Kim JH, Choi JY, Koh SB, Lee Y. Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology 49: 217-222, 2007.","DOI":"10.1007\/s00234-006-0184-y"},{"key":"41","unstructured":"41. Dong X, Cong S. Reversible splenial lesion syndrome associated with acute Mycoplasma pneumoniae-associated encephalitis: A report of four cases and literature review. Exp Ther Med 16: 2152-2159, 2018."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Wang L, Wang X, Shi X, Qiu W, Miao A. Reversible lesion involving the splenium of the corpus callosum caused by phenytoin sodium withdrawal. Neurol Sci 38: 689-691, 2017.","DOI":"10.1007\/s10072-016-2773-9"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Kang K, Song YM, Jo KD, Roh JK. Diffuse lesion in the splenium of the corpus callosum in patients with methyl bromide poisoning. J Neurol Neurosurg Psychiatry 77: 703-704, 2006.","DOI":"10.1136\/jnnp.2005.076620"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Gawlitza M, Hoffmann KT, Lobsien D. Mild encephalitis\/encephalopathy with reversible splenial and cerebellar lesions (MERS type II) in a patient with hemolytic uremic syndrome (HUS). J Neuroimaging 25: 145-146, 2015.","DOI":"10.1111\/jon.12089"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Degirmenci E, Degirmenci T, Cetin EN, Kiroglu Y. Mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS) in a patient presenting with papilledema. Acta Neurol Belg 115: 153-155, 2015.","DOI":"10.1007\/s13760-014-0314-y"},{"key":"46","unstructured":"46. Li C, Wu X, Qi H, et al. Reversible splenial lesion syndrome associated with lobar pneumonia: case report and review of literature. Medicine (Baltimore) 95: e4798, 2016."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Oaklander AL, Buchbinder BR. Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness? Ann Neurol 58: 309-312, 2005.","DOI":"10.1002\/ana.20583"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Miyakawa Y, Fuchigami T, Aoki M, et al. Agraphia with reversible splenial corpus callosum lesion caused by hypoglycemia. Brain Dev 40: 592-595, 2018.","DOI":"10.1016\/j.braindev.2018.03.003"},{"key":"49","unstructured":"49. Ma X, Su W, Chen H. Reversible splenial lesion syndrome after blood transfusion presents callosal disconnection syndrome: a case report. Medicine (Baltimore) 97: e11127, 2018."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Lebecque O, Mulquin N, Dupont M. Cytotoxic lesion of the corpus callosum caused by puumala hantavirus infection. J Belg Soc Radiol 103: 11, 2019.","DOI":"10.5334\/jbsr.1616"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Gruhbaum B, Salzer H, Nasel C, Lernbass I. Reversible cytotoxic oedema in the splenium of the corpus callosum related to tetracycline therapy. Pediatr Radiol 40: 1693-1695, 2010.","DOI":"10.1007\/s00247-010-1745-0"},{"key":"52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00234-006-0116-x","volume":"48","author":"AJ da Rocha","year":"2006","unstructured":"52. Rocha AJ da, Reis F, Gama HP, et al. Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients. Neuroradiology 48: 731-735, 2006.","journal-title":"Neuroradiology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3940","issn-type":"print"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Steiner T, Ettinger J, Peng Z, et al. Hyperintense lesion in the corpus callosum associated with Puumala hantavirus infection. J Neurol 259: 1742-1745, 2012.","DOI":"10.1007\/s00415-012-6437-2"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Samanta D. Transient lesion in the splenium of the corpus callosum in status migrainosus. Acta Neurol Belg 115: 397-398, 2015.","DOI":"10.1007\/s13760-014-0355-2"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Winslow H, Mickey B, Frohman EM. Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion. Arch Neurol 63: 135-137, 2006.","DOI":"10.1001\/archneur.63.1.135"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Shibuya H, Osamura K, Hara K, Hisada T. Clinically mild encephalitis\/encephalopathy with a reversible splenial lesion due to <i>Mycoplasma pneumoniae<\/i> infection. Intern Med 51: 1647-1648, 2012.","DOI":"10.2169\/internalmedicine.51.7676"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Conry RM, Sullivan JC, Nabors LB 3rd. Ipilimumab-induced encephalopathy with a reversible splenial lesion. Cancer Immunol Res 3: 598-601, 2015.","DOI":"10.1158\/2326-6066.CIR-15-0035"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Mitaki S, Onoda K, Ishihara M, Nabika Y, Yamaguchi S. Dysfunction of default-mode network in encephalopathy with a reversible corpus callosum lesion. J Neurol Sci 317: 154-156, 2012.","DOI":"10.1016\/j.jns.2012.02.020"},{"key":"59","unstructured":"59. Bulakbasi N, Kocaoglu M, Tayfun C, Ucoz T. Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis\/encephalopathy. AJNR Am J Neuroradiol 27: 1983-1986, 2006."},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Tascilar N, Aydemir H, Emre U, Unal A, Atasoy HT, Ekem S. Unusual combination of reversible splenial lesion and meningitis-retention syndrome in aseptic meningomyelitis. Clinics (Sao Paulo) 64: 932-937, 2009.","DOI":"10.1590\/S1807-59322009000900017"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Alakbarova N, Eraslan C, Celebisoy N, Karasoy H, Gonul AS. Mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS) development after Amanita phalloides intoxication. Acta Neurol Belg 116: 211-213, 2016.","DOI":"10.1007\/s13760-015-0525-x"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Ko SY, Kim BK, Kim DW, et al. Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy. Clin Mol Hepatol 20: 398-401, 2014.","DOI":"10.3350\/cmh.2014.20.4.398"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Hibino M, Horiuchi S, Okubo Y, Kakutani T, Ohe M, Kondo T. Transient hemiparesis and hemianesthesia in an atypical case of adult-onset clinically mild encephalitis\/encephalopathy with a reversible splenial lesion associated with adenovirus infection. Intern Med 53: 1183-1185, 2014.","DOI":"10.2169\/internalmedicine.53.1966"},{"key":"64","unstructured":"64. Takanashi J, Barkovich AJ, Shiihara T, et al. Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol 27: 836-838, 2006."},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Takanashi J, Hirasawa K, Tada H. Reversible restricted diffusion of entire corpus callosum. J Neurol Sci 247: 101-104, 2006.","DOI":"10.1016\/j.jns.2006.03.015"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Cho JS, Ha SW, Han YS, et al. Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bilateral frontal white matter. J Clin Neurol 3: 53-56, 2007.","DOI":"10.3988\/jcn.2007.3.1.53"},{"key":"67","unstructured":"67. Hagemann G, Mentzel HJ, Weisser H, Kunze A, Terborg C. Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR Am J Neuroradiol 27: 1447-1449, 2006."},{"key":"68","unstructured":"68. Kitami M, Kubo S, Nakamura S, Shiozawa S, Isobe H, Furukawa Y. Acute urinary retention in a 23-year-old woman with mild encephalopathy with a reversible splenial lesion: a case report. J Med Case Rep 5: 159, 2011."},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Shankar B, Narayanan R, Muralitharan P, Ulaganathan B. Evaluation of mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS) by diffusion-weighted and diffusion tensor imaging. BMJ Case Rep 2014: bcr2014204078, 2014.","DOI":"10.1136\/bcr-2014-204078"},{"key":"70","doi-asserted-by":"publisher","unstructured":"70. Bottcher J, Kunze A, Kurrat C, et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 36: e20-e22, 2005.","DOI":"10.1161\/01.STR.0000155733.65215.c2"},{"key":"71","doi-asserted-by":"publisher","unstructured":"71. Oster J, Doherty C, Grant PE, Simon M, Cole AJ. Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia 44: 852-854, 2003.","DOI":"10.1046\/j.1528-1157.2003.40902.x"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Narita H, Odawara T, Kawanishi C, Kishida I, Iseki E, Kosaka K. Transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine. Psychiatry Clin Neurosci 57: 550-551, 2003.","DOI":"10.1046\/j.1440-1819.2003.01164.x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Nishimura K, Takei N, Suzuki K, et al. A transient lesion in splenium of the corpus callosum in a patient with childhood-onset anorexia nervosa. Int J Eat Disord 39: 527-529, 2006.","DOI":"10.1002\/eat.20280"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Okada K, Fujiwara H, Tsuji S. X-linked Charcot-Marie-Tooth disease with transient splenium lesion on MRI. Intern Med 45: 33-34, 2006.","DOI":"10.2169\/internalmedicine.45.1477"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Agarwal A, Kanupriya V, Maller V. Transient restricted diffusion in the splenium of the corpus callosum in migraine with aura. Wien Klin Wochenschr 124: 146-147, 2012.","DOI":"10.1007\/s00508-011-0113-x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4516-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T19:24:11Z","timestamp":1723145051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/20\/59_4516-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":75,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4516-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}